Skip to main content

This website uses cookies. By continuing to use this website, you consent to our use of these cookies. Read more about our use of cookies.

I agree

Main navigation (without target group)

About Sobi
Countries and Products
- United States
- Canada
Investigator Sponsored Studies
News
Careers
Contact Us

Breadcrumb

Home
News

News archive

A news archive from Sobi in North America

Data to be highlighted at the American Society of Hematology 2019 Annual Meeting

12/09/2019 - 19:30

Sobi successfully completes acquisition of Dova Pharmaceuticals

11/13/2019 - 16:16

Sobi publishes report for third quarter 2019

11/13/2019 - 16:14

Load More

Global News

Results from pivotal phase 2/3 study of emapalumab in patients with primary HLH published in New England Journal of Medicine.

More Global News

Filter by Year

News archive

A news archive from Sobi in North America

Data to be highlighted at the American Society of Hematology 2019 Annual Meeting

12/09/2019 - 19:30

Sobi successfully completes acquisition of Dova Pharmaceuticals

11/13/2019 - 16:16

Sobi publishes report for third quarter 2019

11/13/2019 - 16:14

Load More

Global News

Results from pivotal phase 2/3 study of emapalumab in patients with primary HLH published in New England Journal of Medicine.

More Global News

Filter by Year

Footer Menu

Cookies
Terms of use

Copyright Notice: © Sobi, Inc. 2018

This site contains medical information that is intended for residents of the United States and Canada only and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy

Sobi United States
+1 781-786-7370
890 Winter Street
Waltham, MA 02451, USA

Sobi Canada
+1 289-291-3852
1155 North Service Rd. West, Unit #11,
Oakville, Ontario, Canada L6M 3E3